Agomab Therapeutics Nv/Adr
CIK 2104168 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Agomab Therapeutics Nv/Adr.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jan 30, 2026 | EFFECT | 9999999995-26-000429 |
| Jan 26, 2026 | F-6 | 0001019155-26-000020 |